147 related articles for article (PubMed ID: 15145573)
41. DNA/RNA hybrid substrates modulate the catalytic activity of purified AID.
Abdouni HS; King JJ; Ghorbani A; Fifield H; Berghuis L; Larijani M
Mol Immunol; 2018 Jan; 93():94-106. PubMed ID: 29161581
[TBL] [Abstract][Full Text] [Related]
42. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets.
Chaudhuri J; Khuong C; Alt FW
Nature; 2004 Aug; 430(7003):992-8. PubMed ID: 15273694
[TBL] [Abstract][Full Text] [Related]
43. Activation-induced cytidine deaminase induces DNA break repair events more frequently in the Ig switch region than other sites in the mammalian genome.
Lee SA; Parsa JY; Martin A; Baker MD
Eur J Immunol; 2007 Dec; 37(12):3529-39. PubMed ID: 18034427
[TBL] [Abstract][Full Text] [Related]
44. Secret sharers in the immune system: a novel RNA editing activity links switch recombination and somatic hypermutation.
Maizels N
Genome Biol; 2000; 1(4):REVIEWS1025. PubMed ID: 11178252
[TBL] [Abstract][Full Text] [Related]
45. DNA deamination in immunity: AID in the context of its APOBEC relatives.
Conticello SG; Langlois MA; Yang Z; Neuberger MS
Adv Immunol; 2007; 94():37-73. PubMed ID: 17560271
[TBL] [Abstract][Full Text] [Related]
46. Why does somatic hypermutation by AID require transcription of its target genes?
Storb U
Adv Immunol; 2014; 122():253-77. PubMed ID: 24507160
[TBL] [Abstract][Full Text] [Related]
47. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
[TBL] [Abstract][Full Text] [Related]
48. The activation-induced cytidine deaminase (AID) efficiently targets DNA in nucleosomes but only during transcription.
Shen HM; Poirier MG; Allen MJ; North J; Lal R; Widom J; Storb U
J Exp Med; 2009 May; 206(5):1057-71. PubMed ID: 19380635
[TBL] [Abstract][Full Text] [Related]
49. The importance of codon context for understanding the Ig-like somatic hypermutation strand-biased patterns in TP53 mutations in breast cancer.
Lindley RA
Cancer Genet; 2013 Jun; 206(6):222-6. PubMed ID: 23880211
[TBL] [Abstract][Full Text] [Related]
50. Reward versus risk: DNA cytidine deaminases triggering immunity and disease.
Pham P; Bransteitter R; Goodman MF
Biochemistry; 2005 Mar; 44(8):2703-15. PubMed ID: 15723516
[TBL] [Abstract][Full Text] [Related]
51. Activation-induced cytidine deaminase acts on double-strand breaks in vitro.
Shen HM
Mol Immunol; 2007 Feb; 44(5):974-83. PubMed ID: 16697045
[TBL] [Abstract][Full Text] [Related]
52. Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition.
Navaratnam N; Fujino T; Bayliss J; Jarmuz A; How A; Richardson N; Somasekaram A; Bhattacharya S; Carter C; Scott J
J Mol Biol; 1998 Jan; 275(4):695-714. PubMed ID: 9466941
[TBL] [Abstract][Full Text] [Related]
53. Expansions, diversification, and interindividual copy number variations of AID/APOBEC family cytidine deaminase genes in lampreys.
Holland SJ; Berghuis LM; King JJ; Iyer LM; Sikora K; Fifield H; Peter S; Quinlan EM; Sugahara F; Shingate P; Trancoso I; Iwanami N; Temereva E; Strohmeier C; Kuratani S; Venkatesh B; Evanno G; Aravind L; Schorpp M; Larijani M; Boehm T
Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3211-E3220. PubMed ID: 29555777
[TBL] [Abstract][Full Text] [Related]
54. Generation of Genomic Alteration from Cytidine Deamination.
Liu X; Meng FL
Adv Exp Med Biol; 2018; 1044():49-64. PubMed ID: 29956291
[TBL] [Abstract][Full Text] [Related]
55. The contested role of uracil DNA glycosylase in immunoglobulin gene diversification.
Longerich S; Storb U
Trends Genet; 2005 May; 21(5):253-6. PubMed ID: 15851057
[TBL] [Abstract][Full Text] [Related]
56. Mutagenesis by AID, a molecule critical to immunoglobulin hypermutation, is not caused by an alteration of the precursor nucleotide pool.
Diaz M; Ray M; Wheeler LJ; Verkoczy LK; Mathews CK
Mol Immunol; 2003 Sep; 40(5):261-8. PubMed ID: 12943798
[TBL] [Abstract][Full Text] [Related]
57. An update on the role of translesion synthesis DNA polymerases in Ig hypermutation.
Diaz M; Lawrence C
Trends Immunol; 2005 Apr; 26(4):215-20. PubMed ID: 15797512
[TBL] [Abstract][Full Text] [Related]
58. Impact of phosphorylation and phosphorylation-null mutants on the activity and deamination specificity of activation-induced cytidine deaminase.
Pham P; Smolka MB; Calabrese P; Landolph A; Zhang K; Zhou H; Goodman MF
J Biol Chem; 2008 Jun; 283(25):17428-39. PubMed ID: 18417471
[TBL] [Abstract][Full Text] [Related]
59. AID binds to transcription-induced structures in c-MYC that map to regions associated with translocation and hypermutation.
Duquette ML; Pham P; Goodman MF; Maizels N
Oncogene; 2005 Sep; 24(38):5791-8. PubMed ID: 15940261
[TBL] [Abstract][Full Text] [Related]
60. The nuclear DNA deaminase AID functions distributively whereas cytoplasmic APOBEC3G has a processive mode of action.
Coker HA; Petersen-Mahrt SK
DNA Repair (Amst); 2007 Feb; 6(2):235-43. PubMed ID: 17161027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
